82 FR 58622 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 238 (December 13, 2017)

Page Range		58622-58622
FR Document		2017-26799

Federal Register, Volume 82 Issue 238 (Wednesday, December 13, 2017)

[Federal Register Volume 82, Number 238 (Wednesday, December 13, 2017)]
[Notices]
[Page 58622]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-26799]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID Investigator Initiated 
Program Project Applications (P01).
    Date: January 17, 2018.
    Time: 11:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 5601 Fishers Lane, 
Rockville, MD 20892, (Telephone Conference Call).
    Contact Person: Eleazar Cohen, Ph.D., Scientific Review Officer, 
Scientific Review Program, Division of Extramural Activities, Room 
3G62A, National Institute of Health, NIAID, 5601 Fishers Lane, MSC 
9823, Bethesda, MD 20899-823, (240) 669-5081, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: December 6, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-26799 Filed 12-12-17; 8:45 am]
 BILLING CODE 4140-01-P

58622 Federal Register / Vol. 82, No. 238 / Wednesday, December 13, 2017 / Notices

collection of information to OMB for communicating with their intended day notice requesting public comment
review and clearance. audiences. on the proposed extension of the
FDA will use these methods to test collection of information. One comment
Data To Support Drug Product and refine its ideas and to help develop
Communications as Used by the Food was received requesting that FDA
messages and other communications but publish an annual list of its planned
and Drug Administration will generally conduct further research drug product communication studies
OMB Control Number 0910–0695— before making important decisions, such and strive to reflect an overall work
Extension as adopting new policies and allocating plan. The comment also noted the rather
or redirecting significant resources to
This information collection supports broad topic areas included in the
support these policies. FDA will use
Agency outreach efforts. Testing of information collection and suggested
this mechanism to test messages about
communication messages in advance of regulated drug products on a variety of that perhaps additional notice regarding
a communication campaign provides an subjects related to consumer, patient, or individual studies would allow for more
important role in improving FDA health care professional perceptions and meaningful feedback on whether that
communications as they allow for an in- about use of drug products and related particular study would be necessary.
depth understanding of individuals’ materials, including but not limited to, FDA appreciates this comment. In
attitudes, beliefs, motivations, and direct-to-consumer prescription drug determining which drug product
feelings. The methods to be employed promotion, physician labeling of communications it will undertake, we
include individual in-depth interviews, prescription drugs, medication guides, first consider those we believe will best
general public focus group interviews, over-the-counter drug labeling, address current or immediate public
intercept interviews, self-administered emerging risk communications, patient health issues. We also note that, in
surveys, gatekeeper surveys, and labeling, online sale of medical accordance with the PRA, any proposed
professional clinician focus group products, and consumer and study under this information collection
interviews, all on a voluntary basis. The professional education. Annually, FDA request must first be submitted to and
methods to be used serve the narrowly projects about 45 communication approved by OMB to determine whether
defined need for direct and informal studies using the variety of test methods it falls within the scope of the
opinion on a specific topic and, as a listed in this document. FDA is collection. At the same time, as
qualitative research tool, have two major requesting an extension of these burden resources are available, we will make
purposes: To obtain information that is hours so as not to restrict the Agency’s every effort to communicate to our
useful for developing variables and ability to gather information on public
measures for formulating the basic stakeholders anticipated studies so that
sentiment for its proposals in its
objectives of risk communication ongoing or related research can be
regulatory and communications
campaigns, and to assess the potential programs. coordinated.
effectiveness of messages and materials In the Federal Register of June 19, We therefore estimate the burden of
in reaching and successfully 2017 (82 FR 27840), we published a 60- this collection of information as follows:
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
Average
Number of
Number of Total annual burden per
Activity responses per Total hours
respondents responses response
respondent (in hours)

Interviews/Surveys ..................................................... 19,822 1 19,822 0.24 (14 minutes) .... 4,757
1 There are no capital costs or operating and maintenance costs associated with this collection of information.

Dated: December 5, 2017. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Program, Division of Extramural Activities,
Leslie Kux, as amended. The grant applications and Room 3G62A, National Institute of Health,
Associate Commissioner for Policy. the discussions could disclose NIAID, 5601 Fishers Lane, MSC 9823,
[FR Doc. 2017–26795 Filed 12–12–17; 8:45 am] confidential trade secrets or commercial Bethesda, MD 20899–823, (240) 669–5081,
property such as patentable material, ecohen@niaid.nih.gov.
BILLING CODE 4164–01–P
and personal information concerning (Catalogue of Federal Domestic Assistance
individuals associated with the grant Program Nos. 93.855, Allergy, Immunology,
DEPARTMENT OF HEALTH AND applications, the disclosure of which and Transplantation Research; 93.856,
HUMAN SERVICES would constitute a clearly unwarranted Microbiology and Infectious Diseases
invasion of personal privacy. Research, National Institutes of Health, HHS)
National Institutes of Health Name of Committee: National Institute of Dated: December 6, 2017.
Allergy and Infectious Diseases Special
National Institute of Allergy and Natasha M. Copeland,
Emphasis Panel; NIAID Investigator Initiated
Infectious Diseases; Notice of Closed Program Project Applications (P01). Program Analyst, Office of Federal Advisory
Meeting Date: January 17, 2018. Committee Policy.
sradovich on DSK3GMQ082PROD with NOTICES

Time: 11:00 a.m. to 4:00 p.m. [FR Doc. 2017–26799 Filed 12–12–17; 8:45 am]
Pursuant to section 10(d) of the
Agenda: To review and evaluate grant BILLING CODE 4140–01–P
Federal Advisory Committee Act, as
applications.
amended, notice is hereby given of the Place: National Institutes of Health, 5601
following meeting. Fishers Lane, Rockville, MD 20892,
The meeting will be closed to the (Telephone Conference Call).
public in accordance with the Contact Person: Eleazar Cohen, Ph.D.,
provisions set forth in sections Scientific Review Officer, Scientific Review

VerDate Sep<11>2014 18:53 Dec 12, 2017 Jkt 244001 PO 00000 Frm 00035 Fmt 4703 Sfmt 9990 E:\FR\FM\13DEN1.SGM 13DEN1

Document Created: 2017-12-13 01:23:59
Document Modified: 2017-12-13 01:23:59

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		January 17, 2018.
FR Citation		82 FR 58622

82 FR 58622 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 82, Issue 238 (December 13, 2017)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health